Psychedelics Headlines: Dementia Prevention, Psychological Flexibility, Ancient Romans' Trips And More

Welcome to Benzinga's psychedelic headlines roundup. This is our pick of must-read news items from the first two weeks of April 2024.See previous edition Psychedelics Headlines: A Form Of Life, Treati

BenzingaApr 17 21:13

Mind Medicine Initiated at Outperform by Leerink Partners

Mind Medicine Initiated at Outperform by Leerink Partners

Dow JonesApr 15 22:39

Mind Medicine (MNMD.US) was first covered by Leerink Partners, which gave it an superior market rating, with a target price of $20.00.

Mind Medicine (MNMD.US) was first covered by Leerink Partners, which gave it an superior market rating, with a target price of $20.00.

Zhitong FinanceApr 15 22:31

Leerink Partners Initiates Coverage On Mind Medicine With Outperform Rating, Announces Price Target of $20

Leerink Partners analyst Rudy Li initiates coverage on Mind Medicine (NASDAQ:MNMD) with a Outperform rating and announces Price Target of $20.

BenzingaApr 15 22:30

Roblox, TAL Education And Other Big Stocks Moving Higher On Wednesday

U.S. stocks were lower, with the Dow Jones index falling over 300 points on Wednesday.

BenzingaApr 10 22:56

Simulations Plus Posts Upbeat, Joins Levi Strauss, BlackBerry And Other Big Stocks Moving Higher In Thursday's Pre-Market Session

U.S. stock futures were higher this morning, with the Dow futures gaining by around 90 points on Thursday. Shares of Simulations Plus, Inc. (NASDAQ:SLP) rose sharply in today's pre-market trading aft

BenzingaApr 4 17:18